Dr. Gustavo A. Calleja, MD

Dr. Calleja practices at Advanced Cardiovascular of Miami in Miami, Florida.

Dr. Calleja's NPI, 1003891029, was assigned on December 13, 2005. Dr. Calleja graduated from University of Miami, Miller School of Medicine in 1982. Dr. Calleja holds Florida license ME43325.

Dr. Calleja's primary practice is Advanced Cardiovascular of Miami, at 9408 Sw 87th Ave, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 474-3211.

Dr. Calleja's primary practice is Advanced Cardiovascular of Miami in Miami, Florida. Dr. Calleja is also affiliated with South Miami Hospital. The medical group on file is Gastro Health. Dmand AI also links Dr. Calleja to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Calleja practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Calleja's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Calleja is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Calleja's licenses on file in 3 states: Florida, South Carolina and Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroenteritis among the conditions Dr. Calleja treats.

CMS data shows 313 Medicare services from Dr. Calleja across 9 procedure codes in 2024, for 229 Medicare patients. Medicare paid $36,940 for them.

CMS counts 229 Medicare patients who saw Dr. Calleja in 2024. The largest group is 65 to 74, with 122 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Calleja's median patient age at 65, with 57% women.

In 2024, Dr. Calleja wrote 1,502 Medicare Part D claims for 558 patients. 75% of them were for generic drugs. CMS names the drug for 1,309 of them, across 20 drugs with 11 or more claims each, at $159,588 in total drug cost. In 2023, CMS named 1,322 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Calleja for performance year 2024, reported as part of a group. Dr. Calleja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Calleja as offering telehealth. CMS counts 50 procedures of colonoscopy by Dr. Calleja, more than 64% of the clinicians it reports for that procedure.

CMS Open Payments shows 521 general payments to Dr. Calleja from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,882.

Dr. Calleja graduated from University of Miami, Miller School of Medicine in 1982.

Dr. Calleja is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.